Evercyte to Showcase at Bio International Convention 2013

Austria-based Evercyte, the leading manufacturer of a range of cell based products is to showcase its services at the annual Bio International Convention 2013 from 22nd – 25th April at the McCormick Place, Chicago, USA.

Evercyte’s Otto Kanzler and Johannes Grillari will be based at stand 4848 in Hall C Austria Pavilion throughout the convention. Here, they will be delighted to meet with those interested in Evercyte’s services, offer advice and discuss individual requirements.

The annual event brings together the world’s leading biotechnology companies and professionals to create a convention which offers the opportunity to network with existing clients and create new business relationships.

About Evercyte
Vienna-based Evercyte GmbH manufacture a range of cell based products, including primary/normal cells, telomerase (hTERT) immortalized or life-span extended cells and/or differentiated cells from immortalized or normal stem cells. Recently, Evercyte developed induced pluripotent stem (iPS) cells from human urine as a non-invasive source for generating cell material. Evercyte has a clear focus on the establishment of cell based assays used e.g. for the development of drug screening strategies which will help its clients’ reduce the time and spend on drug discovery and development.

About Bio International Convention
Bio International Convention is the global event for the biotechnology industry attracting over 16,000 decision makers from 65 countries. The three day event attracts thousands of companies from around the world and helps build strategic partnerships. BIO covers the wide spectrum of life science innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries represented at the BIO International Convention.

For more information or to discuss Evercyte to Showcase at Bio International Convention 2013 please contact Evercyte directly.